SCHEMBL22983345

SCHEMBL22983345

CC1(C)C[C@H](CCC(N)c2ccncc2)CN1C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 4/20 0.33
CYP19A1 P11511 3/20 0.33
DPP4 P27487 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
GRM8 O00222 1/20 0.33
GRM4 Q14833 1/20 0.33
MAPT P10636 1/20 0.33
DPP7 Q9UHL4 1/20 0.32
CCR5 P51681 1/20 0.32
ACHE P22303 1/20 0.32
ARG1 P05089 1/20 0.32
BCDIN3D Q7Z5W3 1/20 0.32
FASN P49327 1/20 0.31
ITGB3 P05106 1/20 0.31
ITGA2B P08514 1/20 0.31
TP53 P04637 1/20 0.31
MDM2 Q00987 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22983268 0.89 ARG1 (0.37) ALDH1A1ARG1
SCHEMBL22983088 0.89 ARG1 (0.37) ALDH1A1ARG1
SCHEMBL23006522 0.84 KDM4D (0.35) CYP19A1
SCHEMBL23006525 0.84 KDM4D (0.35) CYP19A1
SCHEMBL29205511 0.81 ARG1 (0.31) CYP17A1CYP19A1DPP4KDM4EGAA
SCHEMBL22982568 0.80 ALDH1A1 (0.34) CYP17A1DPP4KDM4EGAAALDH1A1
SCHEMBL22982291 0.80 ALDH1A1 (0.37) KDM4EGAAALDH1A1TP53MDM2
SCHEMBL22982690 0.79 HTT (0.37) ALDH1A1ARG1
SCHEMBL22982914 0.78 MDM2 (0.35) TP53MDM2
SCHEMBL22983211 0.78 LMNA (0.33) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013759-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2022-06-22 EP disclosed
WO-2021030556-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-02-18 WO disclosed